BackImmunovia AB Overview

Immunovia AB Receivables

Immunovia AB's receivables is $2.8M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.84M
↑ 712.66% YoYΔ $2.49M vs prior year quarter

Peer trimmed avg / median

Loading

Immunovia AB Receivables History

Loading

Immunovia AB vs. peers: Receivables Comparison

Loading

Immunovia AB Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immunovia AB (IMMNOV.ST) FAQ

Immunovia AB (IMMNOV.ST) currently reports a receivables of $2.8M as of June 2026. That compares with $350K in the prior-year period — up 712.7% year over year. Use the charts on this page to explore Immunovia AB's receivables history and peer comparisons.

Immunovia AB's receivables increased from $350K to $2.8M — a 712.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immunovia AB reported $2.8M in receivables as of June 2026. That compares with $350K in the prior-year period — up 712.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $2.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immunovia AB, and consider following IMMNOV.ST for alerts when major investors trade the stock.